CSF3 and stroke disorder: Although either EPO or G-CSF has been shown to express neuroprotective and angiogenic effects in stroke animal models [1], [6], [19] and limb ischemia [22], no report has yet focused on the enhanced ability of these two cytokines in combination to induce neuroplasticity and angiogenesis.